These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2434058)

  • 21. Roles of NTE protein and encoding gene in development and neurodevelopmental toxicity.
    Sogorb MA; Pamies D; Estevan C; Estévez J; Vilanova E
    Chem Biol Interact; 2016 Nov; 259(Pt B):352-357. PubMed ID: 27475862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlorpyrifos-induced delayed myelopathy and pure motor neuropathy: a case report.
    Thivakaran T; Gamage R; Gunarathne KS; Gooneratne IK
    Neurologist; 2012 Jul; 18(4):226-8. PubMed ID: 22735254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenyl di-n-pentylphosphinate: a convenient reactivatible inhibitor for studies on neuropathy target esterase (NTE) and protection against organophosphate-induced delayed polyneuropathy.
    Johnson MK; Bird I; Meredith C
    Toxicol Lett; 1988 Feb; 40(2):133-40. PubMed ID: 2829392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylmethanesulfonyl fluoride elicits and intensifies the clinical expression of neuropathic insults.
    Moretto A; Bertolazzi M; Capodicasa E; Peraica M; Richardson RJ; Scapellato ML; Lotti M
    Arch Toxicol; 1992; 66(1):67-72. PubMed ID: 1316117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood copper in organophosphate-induced delayed polyneuropathy.
    Lotti M; Caroldi S; Moretto A
    Toxicol Lett; 1988 May; 41(2):175-80. PubMed ID: 2835831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organophosphate induced delayed polyneuropathy.
    Jokanovic M; Stukalov PV; Kosanovic M
    Curr Drug Targets CNS Neurol Disord; 2002 Dec; 1(6):593-602. PubMed ID: 12769600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organophosphate-induced delayed polyneuropathy.
    Lotti M; Moretto A
    Toxicol Rev; 2005; 24(1):37-49. PubMed ID: 16042503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axonal degeneration and neuropathy target esterase.
    Glynn P
    Arh Hig Rada Toksikol; 2007 Sep; 58(3):355-8. PubMed ID: 18050888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, biochemical, electrophysiologic, and histologic assessment of chlorpyrifos induced delayed neuropathy in the cat.
    Fikes JD; Zachary JF; Parker AJ; Beasley VR
    Neurotoxicology; 1992; 13(3):663-78. PubMed ID: 1282230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organophosphate polyneuropathy and neuropathy target esterase: studies with methamidophos and its resolved optical isomers.
    Lotti M; Moretto A; Bertolazzi M; Peraica M; Fioroni F
    Arch Toxicol; 1995; 69(5):330-6. PubMed ID: 7654138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical expression of organophosphate-induced delayed polyneuropathy in rats.
    Moretto A; Capodicasa E; Lotti M
    Toxicol Lett; 1992 Oct; 63(1):97-102. PubMed ID: 1412529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo and in vitro regional differential sensitivity of neuropathy target esterase to di-n-butyl-2,2-dichlorovinyl phosphate.
    Moretto A; Lotti M; Spencer PS
    Arch Toxicol; 1989; 63(6):469-73. PubMed ID: 2619560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
    Makhaeva GF; Sigolaeva LV; Zhuravleva LV; Eremenko AV; Kurochkin IN; Malygin VV; Richardson RJ
    J Toxicol Environ Health A; 2003 Apr; 66(7):599-610. PubMed ID: 12746135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: a critical review of the literature.
    Richardson RJ
    J Toxicol Environ Health; 1995 Feb; 44(2):135-65. PubMed ID: 7531775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of mipafox, paraoxon, chlorpyrifos and its metabolite chlorpyrifos-oxon on the expression of biomarker genes of differentiation in D3 mouse embryonic stem cells.
    Sogorb MA; Fuster E; Del Río E; Estévez J; Vilanova E
    Chem Biol Interact; 2016 Nov; 259(Pt B):368-373. PubMed ID: 27117976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor neuron disease due to neuropathy target esterase gene mutation: clinical features of the index families.
    Rainier S; Albers JW; Dyck PJ; Eldevik OP; Wilcock S; Richardson RJ; Fink JK
    Muscle Nerve; 2011 Jan; 43(1):19-25. PubMed ID: 21171093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neural development and neurodegeneration: two faces of neuropathy target esterase.
    Glynn P
    Prog Neurobiol; 2000 May; 61(1):61-74. PubMed ID: 10759065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promotion of peripheral axonopathies by certain esterase inhibitors.
    Moretto A; Lotti M
    Toxicol Ind Health; 1993; 9(6):1037-46. PubMed ID: 8191502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose intravenous paraoxon exposure does not cause organophosphate-induced delayed neuropathy (OPIDN) in mini pigs.
    Petroianu G; Hardt F; Toomes M; Bergler W; Rüfer R
    J Appl Toxicol; 2001; 21(4):263-8. PubMed ID: 11481657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of the neurotoxic esterase in neurologic pathology of toxic origin. Measurement in human lymphocytes in poisoning by organophosphates, ciguatera and ethyl alcohol].
    Fournier L; Fournier E; Lecorsier A
    Ann Med Interne (Paris); 1987; 138(3):169-72. PubMed ID: 3619246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.